Health In Tech Inc (NASDAQ:HIT) shares, rose in value on Wednesday, February 12, with the stock price up by 3.65% to the previous day’s close as strong demand from buyers drove the stock to $5.97.
Actively observing the price movement in the last trading, the stock closed the session at $5.76, falling within a range of $5.6505 and $6.0794. The PE ratio was 177.68 over 12-month period. Referring to stock’s 52-week performance, its high was $7.12, and the low was $4.82. On the whole, HIT has fluctuated by 10.15% over the past month.
With the market capitalization of Health In Tech Inc currently standing at about $322.80 million, investors are eagerly awaiting this quarter’s results, scheduled for in March.
The stock’s technical analysis shows that the price of HIT currently trading nearly 6.49% and 8.71% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 58.10, while the 7-day volatility ratio is showing 7.45% which for the 30-day chart, stands at 9.09%. Furthermore, Health In Tech Inc (HIT)’s average true range (ATR) is 0.52.
Data on historical trading for Health In Tech Inc (NASDAQ:HIT) indicates that the trading volumes over the past 10 days have averaged 1.2 and over the past 3 months, they’ve averaged 854.52K. According to company’s latest data on outstanding shares, there are 42.37 million shares outstanding.
Nearly 78.30% of Health In Tech Inc’s shares belong to company insiders and institutional investors own 0.00% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 17143.0 shares as on 2025-01-31, resulting in a short ratio of 0.02. According to the data, the short interest in Health In Tech Inc (HIT) stood at 14.00 of shares outstanding as of 2025-01-31; the number of short shares registered in 2024-12-31 reached 37859.0. The stock has risen by 11.48% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the HIT stock heading into the next quarter.
